ARCHIVES

ODAC Says Clear Clinical Benefit Required When Sponsors Claim Progression Delay

This article is from The Cancer Letter archive.

Vol. 35 No. 28 | July 17, 2009

Download PDF Visit The Full Archive

Related Articles

Computer Interpretation Software Does Not Improve Detection

August 26, 2011

NIH Clinical Trials Committee Adopts Recommendations For Safety Monitoring

June 22, 1979

DCCP To Have Board Of Scientific Counselors

September 1, 1978

Congress Renews National Cancer Act, Including Most Key Amendments Sought By NCI And Allied

October 28, 1988

NCI Programs: NCI Drug Screening To Take More Targeted Approach; BSA Okays Plan To Support New MA Contracts

April 3, 1998

In Brief: Fischinger Hints of “New Player” At FCRF; Gigliotti Named Cancer Control Science Director

December 12, 1986